CEL-SCI

+$0.49 (+5.96%) As of 7:22 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CEL-SCI and other ETFs, options, and stocks.

About CVM

CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).

CEO
Geert R. Kersten
Employees
—
Headquarters
Vienna, Virginia
Founded
1983

CVM Key Statistics

Market Cap
1.05B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
881.59K
High Today
$8.86
Low Today
$8.15
Open Price
$8.18
Volume
1.07M
52 Week High
$40.91
52 Week Low
$7.08

CVM Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure